Growing Like a Weed: DigiPath is Building a Cannabis Conglomerate

The cannabis industry is rapidly growing and there are no signs that it’s slowing down anytime soon. According to ArcView Research, the market for legal cannabis is the fastest-growing industry in the United States, growing to $2.7 billion in 2014.

Many publicly traded companies have sought to capitalize on this growth by growing medical cannabis, pursuing clinical trials with cannabinoids, developing vaporizers and other accessories, or providing generic consulting services to the space. While many of these companies are involved in the industry, no clear market leaders have yet to emerge as conglomerates.

For instance, GW Pharmaceuticals plc (NASDAQ: GWPH) is a leader in conducting clinical trials targeting a number of underlying medical conditions. The stock has done very well, but it doesn’t provide diversification across multiple areas of the industry.

Recently, CannabisFN’s Mike Elliott sat down with DigiPath Inc.’s (OTC: DIGP) CEO Todd Denkin to discuss the company’s recent accomplishments in...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.